Page last updated: 2024-08-24

azelnidipine and Cardiac Remodeling, Ventricular

azelnidipine has been researched along with Cardiac Remodeling, Ventricular in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ikeda, U; Izawa, A; Koyama, J; Miyashita, Y; Motoki, H; Takahashi, M; Tomita, T	1
Ito, T; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Ogawa, H; Tanaka, T; Tokutomi, Y; Yamamoto, E; Yamashita, T	1
Enomoto, S; Iwao, H; Izumi, Y; Kusuyama, T; Matsumoto, R; Nishiya, D; Omura, T; Takeuchi, K; Yoshiyama, M	1

Trials

1 trial(s) available for azelnidipine and Cardiac Remodeling, Ventricular

Article	Year
Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy. Echocardiography (Mount Kisco, N.Y.), 2014, Volume: 31, Issue:10 Topics: Adult; Aged; Amlodipine; Analysis of Variance; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Doppler, Pulsed; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Image Interpretation, Computer-Assisted; Male; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling	2014

Article

Year

Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy.

Echocardiography (Mount Kisco, N.Y.), 2014, Volume: 31, Issue:10

Topics: Adult; Aged; Amlodipine; Analysis of Variance; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Doppler, Pulsed; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Image Interpretation, Computer-Assisted; Male; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling

2014

Other Studies

2 other study(ies) available for azelnidipine and Cardiac Remodeling, Ventricular

Article	Year
Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. Journal of hypertension, 2006, Volume: 24, Issue:10 Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Cardiomegaly; Dihydropyridines; Endomyocardial Fibrosis; Hydralazine; Hypertension; Male; Mitogen-Activated Protein Kinases; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tachycardia; Ventricular Remodeling	2006
The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction. Journal of pharmacological sciences, 2007, Volume: 103, Issue:4 Topics: Animals; Azetidinecarboxylic Acid; Blotting, Northern; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Collagen Type III; Dihydropyridines; Echocardiography; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Organ Size; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling	2007

Article

Year

Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis.

Journal of hypertension, 2006, Volume: 24, Issue:10

Topics: Amlodipine; Animals; Azetidinecarboxylic Acid; Cardiomegaly; Dihydropyridines; Endomyocardial Fibrosis; Hydralazine; Hypertension; Male; Mitogen-Activated Protein Kinases; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tachycardia; Ventricular Remodeling

2006

The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction.

Journal of pharmacological sciences, 2007, Volume: 103, Issue:4

Topics: Animals; Azetidinecarboxylic Acid; Blotting, Northern; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Collagen Type III; Dihydropyridines; Echocardiography; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Organ Size; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling

2007